Chi DS - Search Results

1

Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study.

Zivanovic O, Chi DS, Zhou Q, Iasonos A, Konner JA, Makker V, Grisham RN, Brown AK, Nerenstone S, Diaz JP, Schroeder ED, Langstraat CL, Paroder V, Lakhman Y, Soldan K, Su K, Gardner GJ, Andikyan V, Guo J, Jewell EL, Long Roche K, Troso-Sandoval T, Lichtman SM, Moukarzel LA, Dessources K, Abu-Rustum NR, Aghajanian C, Tew WP, Beumer J, Sonoda Y, O'Cearbhaill RE. Zivanovic O, et al. Among authors: chi ds. J Clin Oncol. 2021 Aug 10;39(23):2594-2604. doi: 10.1200/JCO.21.00605. Epub 2021 May 21. J Clin Oncol. 2021. PMID: 34019431 Free PMC article. Clinical Trial.

2

Epithelial ovarian cancer.

Abu-Rustum NR, Chi DS, Curtin JP. Abu-Rustum NR, et al. Among authors: chi ds. Curr Probl Surg. 1999 Jan;36(1):1-53. doi: 10.1016/s0011-3840(99)80005-7. Curr Probl Surg. 1999. PMID: 9924485 Review. No abstract available.

3

Splenectomy in recurrent epithelial ovarian cancer.

Gemignani ML, Chi DS, Gurin CC, Curtin JP, Barakat RR. Gemignani ML, et al. Among authors: chi ds. Gynecol Oncol. 1999 Mar;72(3):407-10. doi: 10.1006/gyno.1998.5141. Gynecol Oncol. 1999. PMID: 10053114 Review.

4

The accuracy of frozen-section diagnosis in metastatic breast and colorectal carcinoma to the adnexa.

Abu-Rustum NR, Chi DS, Wiatrowska BA, Guiter G, Saigo PE, Barakat RR. Abu-Rustum NR, et al. Among authors: chi ds. Gynecol Oncol. 1999 Apr;73(1):102-5. doi: 10.1006/gyno.1998.5312. Gynecol Oncol. 1999. PMID: 10094888

5

Primary intravenous paclitaxel and platinum chemotherapy for high-risk Stage I epithelial ovarian carcinoma.

Chi DS, Waltzman RJ, Barakat RR, Spriggs DR. Chi DS, et al. Eur J Gynaecol Oncol. 1999;20(4):277-80. Eur J Gynaecol Oncol. 1999. PMID: 10475122

6

The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.

Chi DS, Venkatraman ES, Masson V, Hoskins WJ. Chi DS, et al. Gynecol Oncol. 2000 May;77(2):227-31. doi: 10.1006/gyno.2000.5749. Gynecol Oncol. 2000. PMID: 10785469

7

Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.

Boyd J, Sonoda Y, Federici MG, Bogomolniy F, Rhei E, Maresco DL, Saigo PE, Almadrones LA, Barakat RR, Brown CL, Chi DS, Curtin JP, Poynor EA, Hoskins WJ. Boyd J, et al. Among authors: chi ds. JAMA. 2000 May 3;283(17):2260-5. doi: 10.1001/jama.283.17.2260. JAMA. 2000. PMID: 10807385

8

The role of laparoscopy in second-look evaluations for ovarian cancer.

Husain A, Chi DS, Prasad M, Abu-Rustum N, Barakat RR, Brown CL, Poynor EA, Hoskins WJ, Curtin JP. Husain A, et al. Among authors: chi ds. Gynecol Oncol. 2001 Jan;80(1):44-7. doi: 10.1006/gyno.2000.6036. Gynecol Oncol. 2001. PMID: 11136568

9

Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.

Hensley ML, Lebeau D, Leon LF, Venkatraman E, Waltzman R, Sabbatini P, Almadrones L, Chi D, Spriggs D. Hensley ML, et al. Gynecol Oncol. 2001 Jun;81(3):485-9. doi: 10.1006/gyno.2001.6185. Gynecol Oncol. 2001. PMID: 11371143

10

The costs and efficacy of liposomal doxorubicin in platinum-refractory ovarian cancer in heavily pretreated patients.

Hensley ML, Hoppe B, Leon L, Sabbatini P, Aghajanian C, Chi D, Spriggs DR. Hensley ML, et al. Gynecol Oncol. 2001 Sep;82(3):464-9. doi: 10.1006/gyno.2001.6299. Gynecol Oncol. 2001. PMID: 11520141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

475 results

Search Page